FORM 3
--------------------------
OMB APPROVAL
--------------------------
OMB Number: 3235-0104
Expires:September 30, 1998
Estimated average burden
hours per response.....0.5
--------------------------
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section
17(a) of the Public Utility Holding Company Act of 1935 or Section 30(f) of the
Investment Company Act of 1940
(Print or Type Responses)
- -----------------------------------------------------------
1. Name and Address of Reporting Person*
General Electric Company
- -----------------------------------------------------------
(Last) (First) (Middle)
3135 Easton Turnpike
- -----------------------------------------------------------
(Street)
Fairfield CT 06431-0001
- -----------------------------------------------------------
(City) (State) (Zip)
- -----------------------------------------------------------
2. Date of Event Requiring Statement
(Month/Day/Year)
8/7/99
- -----------------------------------------------------------
3. IRS or Social Security Number of Reporting Person
(Voluntary)
- -----------------------------------------------------------
4. Issuer Name and Ticker or Trading Symbol
OEC Medical Systems, Inc. (OXE)
- -----------------------------------------------------------
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director X 10% Owner
Officer (give title below) Other (specify below)
- -----------------------------------------------------------
6. If Amendment, Date of
Original (Month/Day/Year)
- -----------------------------------------------------------
7. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
<PAGE>
<TABLE>
Table I -- Non-Derivative Securities Beneficially Owned
<CAPTION>
- ------------------------------------------------------------------------------------------------------------------------------
1. Title of Security 2. Amount of Securities 3. Ownership 4. Nature of Indirect Beneficial Ownership
(Instr. 4) Beneficially Owned Form: Direct (Instr. 5)
(Instr. 4) (D) or Indirect
(I) (Instr. 5)
<S> <C> <C> <C>
- ------------------------------------------------------------------------------------------------------------------------------
- ------------------------------------------------------------------------------------------------------------------------------
</TABLE>
Reminder: Report on a separate line for each class of securities
beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction
5(b)(v).
<PAGE>
FORM 3 (continued)
<TABLE>
Table II -- Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
<CAPTION>
- -----------------------------------------------------------------------------------------------------------------------------------
<C>
1. Title of 2. Date Exer- 3. Title and Amount 4. Conversion 5. Ownership 6. Nature of
Derivative cisable and of Securities or Form of Indirect
Security Expiration Underlying Exercise Derivative Beneficial
(Instr. 4) Date Derivative Price of Security: Ownership
(Month/Day/ Security Derivative Direct (D) or (Instr. 5)
Year) Security Indirect (I)
------------------ --------------------- (Instr. 5)
Date Expira- Title Amount
Exer- tion or
cisable Date Number
of
Shares
<C> <C> <C> <C> <C> <C>
- -----------------------------------------------------------------------------------------------------------------------------------
Stock Option Note 1 Note 1 Common Stock, 2,243,346 $36.00 D
$.01 par value
</TABLE>
Explanation of Responses:
Note 1: On August 7, 1999, OEC Medical Systems, Inc. ("OEC") granted General
Electric Company ("GE") an option to purchase up to 2,243,346 shares, which,
upon issuance, would represent 15%, of the outstanding OEC common stock. Under
the Stock Option Agreement dated August 7, 1999, as more fully described in the
Schedule 13D filed by GE, the option becomes immediately exercisable upon events
associated with any proposed acquisition of OEC. The option expires upon the
earlier of the closing of the transactions contemplated by the merger agreement
described in GE's Schedule 13D, or the termination of the merger agreement in
accordance with its terms, except that the option will not expire until 12
months after the termination of the merger agreement under certain circumstances
described in the Stock Option Agreement. Relating to proposals to acquire OEC
made by other parties.
**Intentional misstatements or omission of facts constitute Federal
Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed.
If space is insufficient, See Instruction 6 for procedure.
Potential persons who are to respond to the collection of information
contained in this form are not required to respond unless the form displays a
currently valid OMB Number.
Janet Bedol August 17, 1999
- ------------------------------- -----------------
**Signature of Reporting Person Date
Janet Bedol
on behalf of
General Electric Company
